• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. CONFORMABLE GORE TAGTHORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. CONFORMABLE GORE TAGTHORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGU282815
Device Problem No Apparent Adverse Event (3189)
Patient Problem Death (1802)
Event Date 02/22/2019
Event Type  Death  
Manufacturer Narrative
A review of the manufacturing records could not be performed as device lot numbers were not available.The images and device were not available, the imaging evaluation and engineering evaluation could not be performed.(b)(4).
 
Event Description
The following publication was reviewed: " endovascular aortic repair is a viable strategy for treatment of primary infected abdominal aortic aneurysm¿ received through ann vasc surg 2020; 63: 117¿128.The authors: xiao di, changwei liu, rong zeng, and leng ni.The article aimed that infected abdominal aortic aneurysm (iaaa) is rare, and information is limited whether endovascular aortic repair (evar) can be considered a permanent treatment or is a temporary fix preceding open surgery.This retrospective study reviewed the short- and longterm outcomes of open surgery, emergent evar, and elective evar in the treatment of primary iaaa.The study population comprised 19 patients treated for iaaa at peking union medical college hospital between january 2008 and january 2017.Reported results stated there was one death (5.26%) among the 19 patients within the first postoperative 30 days.That patient (patient 4) had a sudden rupture of the abdominal aorta (implanted with gore excluder 28-150) during preoperative antimicrobial treatment and did not survive after the emergent evar procedure(post-op survival: 1 day).
 
Manufacturer Narrative
Patients diagnosed with a pre-existing rupture of the abdominal aorta artery, and whose death is attributed to the pre-existing rupture.Therefore, this event was determined to be non-reportable due to the pre-existing rupture mentioned in the article was not related to gore device.This medwatch will be voided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONFORMABLE GORE TAGTHORACIC ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10342805
MDR Text Key200960659
Report Number2017233-2020-01066
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Type of Report Initial,Followup
Report Date 08/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/30/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberTGU282815
Was Device Available for Evaluation? No
Date Manufacturer Received07/15/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age47 YR
-
-